Head and Neck Squamous Cell Carcinoma Clinical Trials in Seoul
2 recruitingSeoul, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Esophageal Squamous Cell CarcinomaHead and Neck Squamous Cell CarcinomaSquamous Non-small-cell Lung Cancer+1 more
Alentis Therapeutics AG170 enrolled38 locationsNCT06747585
Recruiting
Phase 1Phase 2
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Biliary Tract CancerHead and Neck Squamous Cell CarcinomaSolid Tumor
TiumBio Co., Ltd.140 enrolled11 locationsNCT05784688